AP Biology: CRISPR?Cas9 – Gene Editing Mechanism

CRISPR?Cas9 – Gene Editing Mechanism

Concept Summary

• CRISPR-Cas9: A bacterial adaptive immune system repurposed as a precise gene-editing tool, enabling targeted DNA cleavage and modification in eukaryotic cells.
• Guide RNA (gRNA): A customizable RNA sequence that directs Cas9 to a specific DNA target via base-pairing, critical for editing specificity.
• PAM sequence (Protospacer Adjacent Motif): A 2–6 bp DNA sequence (e.g., NGG for Streptococcus pyogenes Cas9) required immediately downstream of the target site for Cas9 binding and cleavage.
• Double-strand break (DSB): The DNA cut generated by Cas9, which triggers cellular repair pathways (NHEJ or HDR) to introduce edits.
• Off-target effects: Unintended edits at non-target DNA sites due to gRNA mismatches or Cas9 promiscuity, a major limitation of CRISPR technology.

Core Questions

WHAT (definitional)

Q: What is CRISPR-Cas9? A: A programmable gene-editing system derived from bacterial immune defenses, consisting of a Cas9 nuclease and a guide RNA (gRNA) that directs it to a specific DNA sequence. Trap/Clarification: CRISPR is not a single protein—it’s a two-component system (Cas9 + gRNA); "CRISPR" alone refers to the DNA repeats in bacteria, not the editing tool.

Q: What is the role of the PAM sequence? A: The PAM is a short DNA motif required for Cas9 to bind and cleave the target DNA; without it, Cas9 cannot cut, even if the gRNA matches perfectly. Trap/Clarification: PAM sequences vary by Cas9 ortholog (e.g., NGG for S. pyogenes, NAG for some others)—assuming all Cas9s use NGG is a common error.

WHY (causal/explanatory)

Q: Why is the gRNA necessary for CRISPR-Cas9 function? A: The gRNA provides sequence specificity by base-pairing with the target DNA, ensuring Cas9 cuts only at the intended genomic location. Trap/Clarification: The gRNA is not a protein—it’s a hybrid of crRNA (targeting) and tracrRNA (Cas9 binding); confusing it with Cas9’s protein structure is a frequent mistake.

Q: Why is the PAM sequence evolutionarily significant for bacteria? A: PAM sequences distinguish self (bacterial DNA) from non-self (viral DNA) in bacterial immune systems, preventing Cas9 from cutting the host genome. Trap/Clarification: PAMs are not part of the gRNA—students often incorrectly assume the gRNA includes the PAM.

HOW (process/application)

Q: How does CRISPR-Cas9 introduce a gene edit? A: Cas9 creates a double-strand break (DSB) at the target site, which is repaired by:
1. NHEJ (Non-Homologous End Joining): Error-prone, often introduces indels (insertions/deletions) that disrupt the gene.
2. HDR (Homology-Directed Repair): Precise editing using a donor DNA template (requires a homologous sequence). Trap/Clarification: HDR is not the default repair pathway—NHEJ dominates in most cells, making precise edits harder to achieve.

Q: How is gRNA designed for a specific target? A: The gRNA’s 20-nucleotide spacer sequence is designed to be complementary to the target DNA, immediately upstream of a PAM (e.g., NGG), with minimal off-target matches. Trap/Clarification: The gRNA’s 5’ end (first ~10–12 nt) is most critical for specificity—mismatches here are more tolerated than in the "seed" region (last ~8–10 nt).

CAN (conditions/possibilities)

Q: Can CRISPR-Cas9 edit RNA instead of DNA? A: No—Cas9 is a DNA nuclease; however, related systems like Cas13 target RNA, and base editors (e.g., dCas9-APOBEC) can modify DNA without cutting. Trap/Clarification: "CRISPR" is often misused to describe all RNA-targeting tools—only Cas9 (and Cas12) edit DNA.

Q: Under what conditions is HDR preferred over NHEJ for gene editing? A: HDR requires: - A donor DNA template with homology to the target site. - Active cell division (S/G2 phase), as HDR is cell-cycle dependent. - Suppression of NHEJ (e.g., via chemical inhibitors or cell synchronization). Trap/Clarification: HDR efficiency is low in non-dividing cells (e.g., neurons)—assuming it works universally is a common error.

Quick Facts & Traps

• Fact: Cas9 orthologs (e.g., S. pyogenes, S. aureus) have different PAM requirements, sizes, and efficiencies—SpCas9 (NGG) is most common but too large for some viral delivery systems.
• Trap: "CRISPR cuts DNA at any sequence."-Reality: Cas9 only cuts where the gRNA matches and a PAM is present.
• Fact: dCas9 (dead Cas9) is a catalytically inactive variant used for gene regulation (e.g., CRISPRa/i) or imaging (via fluorescent tags) without cutting DNA.
• Trap: "All CRISPR edits are permanent."-Reality: Edits can be reversed if the original sequence is restored (e.g., via HDR with a wild-type template) or if the cell repairs the DSB incorrectly.
• Fact: Off-target effects are minimized by:
• High-fidelity Cas9 variants (e.g., eSpCas9, Cas9-HF1).
• Truncated gRNAs (17–18 nt) to reduce mismatch tolerance.
• Bioinformatics tools (e.g., CRISPResso, CCTop) to predict off-targets.
• Trap: "CRISPR is 100% precise."-Reality: Off-targets and mosaicism (edits in only some cells) are persistent challenges, especially in embryos.

Rapid-Fire True/False

• Statement: CRISPR-Cas9 can only introduce deletions, not insertions. Answer: FALSE Why the common mistake happens: Students focus on NHEJ (which often causes deletions) but forget HDR can introduce precise insertions using a donor template.

• Statement: The PAM sequence is part of the gRNA. Answer: FALSE Why the common mistake happens: The PAM is adjacent to the gRNA’s target site, leading students to conflate the two; the PAM is DNA, not RNA.

• Statement: CRISPR-Cas9 works in all cell types and organisms. Answer: FALSE Why the common mistake happens: While versatile, delivery (e.g., viral vectors, electroporation) and repair pathway activity (e.g., HDR in non-dividing cells) limit efficiency in some contexts.